You are here

drug pricing

With drug pricing reform potentially closer than ever, Public Citizen pens new letter calling for change

With drug pricing reform potentially closer than ever, Public Citizen pens new letter calling for change

Endpoints

Flag link:

CBO: Proposed Medicare pricing plan could curb drug development

CBO: Proposed Medicare pricing plan could curb drug development

RAPS.org

drug development

Flag link:

CBO warns of almost 60 fewer new drugs over three decades with Medicare drug negotiations bill

CBO warns of almost 60 fewer new drugs over three decades with Medicare drug negotiations bill

Endpoints

Flag link:

‘It’s not really price transparency’: Pharmacies push back on Surescripts, GoodRx deal

‘It’s not really price transparency’: Pharmacies push back on Surescripts, GoodRx deal

MedCity News

Flag link:

House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'

House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'

Endpoints

Flag link:

Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon

Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon

Endpoints

patient advocacy groups

Flag link:

As Biden signals interest in linking drug prices with R&D costs, new study finds costs per NME are increasing

As Biden signals interest in linking drug prices with R&D costs, new study finds costs per NME are increasing

Endpoints

drug development

Flag link:

J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report

J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report

Fierce Pharma

Flag link:

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

Stat

Flag link:

CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule

CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule

FDA Law Blog

Medicare Part B

most favored nation

Flag link:

More brand-name drug prices hiked this year than in all of 2020, study finds

More brand-name drug prices hiked this year than in all of 2020, study finds

Beckers Hospital Review

Flag link:

AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Fierce Pharma

myasthenia gravis

Flag link:

Cost-cutting generics and biosimilars stuck in legal limbo

Cost-cutting generics and biosimilars stuck in legal limbo

MedCity News

Flag link:

Budget proposal to allow Medicare to negotiate prices should 'enrage' seniors, PhRMA says

Budget proposal to allow Medicare to negotiate prices should 'enrage' seniors, PhRMA says

Fierce Pharma

Flag link:

10 most expensive brand name drugs in the US

10 most expensive brand name drugs in the US

Beckers Hospital Review

Flag link:

Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs

Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs

Fierce Pharma

Express Scripts

Flag link:

Biden executive order lifts ban on using march-in rights to lower drug costs

Biden executive order lifts ban on using march-in rights to lower drug costs

Endpoints

march-in rights

Flag link:

Biden to direct moves on drug importation, call for plan to lower drug prices

Biden to direct moves on drug importation, call for plan to lower drug prices

The Hill

drug importaiton

Flag link:

New drug launch prices have doubled since 2005

New drug launch prices have doubled since 2005

Beckers Hospital Review

Medicare Part B

Flag link:

Study: Prices for new cancer drugs double over past decade

Study: Prices for new cancer drugs double over past decade

UPI

Flag link:

Pages